Physician profile
Rolando Rivera
NPI 1295786093
$436,670.41
in general payments reported to CMS, 2019-2025
69 companies · $29K in 2025
The $29K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $41K · 2021: $60K · 2022: $105K · 2023: $131K · 2024: $34K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $122K · Consulting Fee: $33K · Food and Beverage: $17K · Travel and Lodging: $13K · Education: $9,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $121,687.50 |
| Consulting Fee | $32,964.00 |
| Food and Beverage | $16,793.56 |
| Travel and Lodging | $13,074.03 |
| Education | $9,642.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $310,452.14 | 2020-2025 | Urolift, Barrigel, Solesta |
| Neotract INC. | $66,940.61 | 2019-2020 | |
| Axonics, INC. | $12,016.83 | 2020-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $10,925.71 | 2022-2023 | Davinci Xi |
| Valencia Technologies Corporation | $7,883.11 | 2022-2025 | Ecoin Device Kit |
| Sumitomo Pharma America, INC. | $3,174.34 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $3,090.80 | 2020-2025 | |
| Boston Scientific Corporation | $2,585.59 | 2019-2025 | Ams 700, Axonics, Spaceoar System |
| Astellas Pharma US INC | $2,306.49 | 2019-2025 | Xtandi |
| Urovant Sciences INC | $1,685.65 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $1,531.26 | 2019-2025 | Provenge |
| Procept Biorobotics Corporation | $1,427.20 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Uromedica, Incorporated | $1,000.00 | 2022 | |
| Coloplast Corp | $894.02 | 2019-2025 | Porges Coloplast, Speedicath, Virtue |
| Janssen Biotech, INC. | $880.07 | 2019-2025 | Erleada, Rybrevant, Carvykti |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $681.95 | 2019-2025 | Adstiladrin |
| Medtronic, INC. | $621.50 | 2022-2025 | Interstim |
| Endo Pharmaceuticals INC. | $599.78 | 2019-2023 | Xiaflex, Edex, Aveed |
| Srs Medical Systems, INC. | $571.19 | 2019-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Abbvie INC. | $561.16 | 2019-2025 | Botox |
| Astrazeneca Pharmaceuticals LP | $537.22 | 2022-2025 | Lynparza |
| Pfizer INC. | $416.78 | 2019-2025 | |
| Ambu INC. | $368.10 | 2021-2025 | |
| Urogen Pharma, INC. | $343.99 | 2021-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $337.60 | 2019-2025 | Lynparza, Keytruda |
| Blue Earth Diagnostics | $320.09 | 2019-2025 | Posluma |
| Photocure INC | $309.76 | 2022-2023 | Cysview |
| Olympus America INC. | $294.91 | 2022-2025 | Itind System |
| Baudax Bio INC. | $254.08 | 2021 | |
| Novartis Pharmaceuticals Corporation | $209.72 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $208.89 | 2021-2024 | Prolaris |
| Bioprotect Medical, INC. | $204.11 | 2024-2025 | Bioprotect Balloon Implant System |
| Palette Life Sciences, INC. | $187.30 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $168.55 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Aquarius Lt |
| Myovant Sciences INC. | $162.00 | 2021-2022 | |
| Endo USA, INC. | $155.86 | 2024-2025 | Xiaflex, Aveed, Edex |
| Telix Pharmaceuticals | $151.78 | 2024 | Illuccix |
| Antares Pharma, INC. | $149.27 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Tolmar Pharmaceuticals, INC. | $149.00 | 2020-2022 | |
| Calyxo, INC. | $147.87 | 2022 | |
| Baxter Healthcare | $145.25 | 2025 | Tisseel |
| Allergan, INC. | $135.05 | 2019-2022 | |
| Tolmar, INC. | $134.83 | 2023-2025 | Eligard, Jatenzo |
| Novo Nordisk INC | $111.44 | 2025 | |
| Femselect INC. | $109.71 | 2024 | Enplace |
| Amgen INC. | $108.33 | 2019-2022 | |
| Bluewind Medical | $106.27 | 2025 | |
| Caldera Medical, INC | $104.36 | 2023 | Desara |
| Medtronic USA, INC. | $103.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $94.24 | 2024-2025 | |
| Rochester Medical Corporation | $80.37 | 2019 | |
| Urogpo LLC | $70.19 | 2020 | |
| Accord Healthcare, INC. | $65.82 | 2022-2024 | |
| C. R. Bard, INC. & Subsidiaries | $61.67 | 2019 | |
| Progenics Pharmaceuticals, INC. | $50.45 | 2023-2024 | Pylarify |
| Alnylam Pharmaceuticals INC. | $41.68 | 2021-2022 | |
| Dentsply Ih INC. | $31.48 | 2022 | |
| Acerus Pharmaceuticals Corporation | $27.14 | 2021 | |
| Civco Medical Instruments | $25.17 | 2025 | |
| Innovation Technologies INC | $23.96 | 2022 | |
| Immunitybio, INC. | $22.89 | 2024 | |
| Becton, Dickinson and Company | $17.77 | 2025 | Bard Urinary Drainage Bag |
| Travere Therapeutics, INC. | $17.39 | 2020 | |
| Metuchen Pharmaceuticals | $17.22 | 2020 | |
| Cycle Pharmaceuticals INC | $16.58 | 2025 | Venxxiva |
| Halozyme INC | $15.44 | 2023 | |
| Profound Medical Corp. | $14.15 | 2022 | |
| Mission Pharmacal Company | $11.29 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.